The sword, the shield, the olive branch – NuCurrent’s path to IP value creation
In an exclusive interview, the company’s CEO Jacob Babcock details its journey to becoming a technology licensing business
In an exclusive interview, the company’s CEO Jacob Babcock details its journey to becoming a technology licensing business
After a lull in biologic versus imitator disputes, Regeneron has sued Mylan and more litigation is likely to follow
In an exclusive interview Biocon Biologics’ chief IP counsel explains the issues that he and his team focus on – and how an upcoming, big-ticket merger will lead to change
Despite holding thousands of patents and being active for over 20 years, Docket Navigator data shows that the firm’s entities have filed just 32 litigation actions since 2008
15 August 2022
The search giant has also hit the smart-speaker innovator with a new round of US district court litigation
12 August 2022
Contrary to appearances, Latin America’s largest economy is developing a more favourable environment for pharma and biotech innovators.
12 August 2022
A strategic review that began in December 2021 is ongoing with several options being explored and meanwhile the firm continues to do deals
11 August 2022
The Swedish company has been a prolific filer in a country whose judicial processes strongly favour plaintiffs
11 August 2022
The High Court ruling is the country’s first on whether the use of the online platform’s IP procedures can constitute an actionable unjustified threat
11 August 2022
The Asia-Pacific region’s premier event about the business of IP will take place in the Japanese capital from 31 October to 2 November
10 August 2022
The judgment of the Ankara IP court in a case involving a marketing authorisation application demonstrates that an exemption similar to the so-called Bolar exemption can apply to Gx pharmaceutical companies.
10 August 2022
Paul Davis plans to continue driving growth in the firm’s media and semiconductor IP portfolios
09 August 2022
The Federal Circuit’s recent Thaler v Vidal ruling may create opportunities for accused infringers to challenge the validity of rights that claim inventions obtained, even in part, through such systems
09 August 2022
Get unlimited access to all IAM content